Your browser is no longer supported

For the best possible experience using our website we recommend you upgrade to a newer version or another browser.

Your browser appears to have cookies disabled. For the best experience of this website, please enable cookies in your browser

We'll assume we have your consent to use cookies, for example so you won't need to log in each time you visit our site.
Learn more

Lung cancer treatment 'improves survival rates'

  • Comment

Stereotactic radiotherapy reduces treatment costs while improving overall survival and local control in comparison to standard fractionated radiation therapy in patients with medically inoperable non-small-cell lung cancer.

That is the message from American researchers who monitored the responses of 86 patients with the disease.

The former treatment was found to be less expensive and improved survival rates, with 71% of patients surviving for 36 months, as opposed to 42%.

  • Comment

Have your say

You must sign in to make a comment

Please remember that the submission of any material is governed by our Terms and Conditions and by submitting material you confirm your agreement to these Terms and Conditions. Links may be included in your comments but HTML is not permitted.

Related Jobs